Rapid A1c Test Aims to Reduce Diabetes Diagnosis Inaccuracies
Orange Biomed is currently conducting studies of a rapid A1c, a glycated hemoglobin analyzer through single-cell analysis of red blood cells.
Read MorePosted by Chris Wolski | Apr 19, 2023 | Diabetes & Metabolic Diseases, POC Instruments |
Orange Biomed is currently conducting studies of a rapid A1c, a glycated hemoglobin analyzer through single-cell analysis of red blood cells.
Read MorePosted by Andy Lundin | Apr 13, 2023 | Point-of-Care |
AMDI was awarded funding from the NIH Rapid Acceleration of Diagnostics (RADx) Tech program in support of its RT-PCR point-of-care system.
Read MorePosted by Andy Lundin | Apr 12, 2023 | Company News |
AXIM Biotechnologies announced the start of manufacturing of both its proprietary Ocular IgE and Lactoferrin diagnostic assays.
Read MorePosted by Andy Lundin | Apr 10, 2023 | Sexually Transmitted Diseases |
A quick diagnostic test developed by a Washington State University researcher may help curb the prevalent STI Trichomonas vaginalis.
Read MorePosted by Chris Wolski | Apr 7, 2023 | Lab Automation |
LIMS/LIS automation will ensure a lab’s competitiveness and long-term sustainability in today’s evolving health care market.
Read More